CN114858947A - Detection method of alpha-dicarbonyl compound and application thereof - Google Patents
Detection method of alpha-dicarbonyl compound and application thereof Download PDFInfo
- Publication number
- CN114858947A CN114858947A CN202210628793.6A CN202210628793A CN114858947A CN 114858947 A CN114858947 A CN 114858947A CN 202210628793 A CN202210628793 A CN 202210628793A CN 114858947 A CN114858947 A CN 114858947A
- Authority
- CN
- China
- Prior art keywords
- derivatization
- mobile phase
- dicarbonyl
- detecting
- liquid chromatography
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000001514 detection method Methods 0.000 title claims abstract description 40
- 238000001212 derivatisation Methods 0.000 claims abstract description 62
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical group OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims abstract description 42
- 238000006243 chemical reaction Methods 0.000 claims abstract description 36
- 238000000034 method Methods 0.000 claims abstract description 35
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 claims abstract description 30
- 239000003153 chemical reaction reagent Substances 0.000 claims abstract description 22
- JJWCTKUQWXYIIU-UHFFFAOYSA-N 2-Benzimidazolylguanidine Chemical compound C1=CC=C2NC(N=C(N)N)=NC2=C1 JJWCTKUQWXYIIU-UHFFFAOYSA-N 0.000 claims abstract description 17
- 238000004811 liquid chromatography Methods 0.000 claims abstract description 16
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 claims abstract description 14
- 235000019253 formic acid Nutrition 0.000 claims abstract description 14
- 238000001294 liquid chromatography-tandem mass spectrometry Methods 0.000 claims abstract description 7
- 239000002904 solvent Substances 0.000 claims abstract description 7
- 239000007864 aqueous solution Substances 0.000 claims abstract description 6
- 238000002156 mixing Methods 0.000 claims abstract description 5
- AIJULSRZWUXGPQ-UHFFFAOYSA-N Methylglyoxal Chemical compound CC(=O)C=O AIJULSRZWUXGPQ-UHFFFAOYSA-N 0.000 claims description 34
- LEQAOMBKQFMDFZ-UHFFFAOYSA-N glyoxal Chemical compound O=CC=O LEQAOMBKQFMDFZ-UHFFFAOYSA-N 0.000 claims description 32
- 239000000243 solution Substances 0.000 claims description 20
- 229940015043 glyoxal Drugs 0.000 claims description 16
- 238000004458 analytical method Methods 0.000 claims description 14
- 238000004949 mass spectrometry Methods 0.000 claims description 13
- QSJXEFYPDANLFS-UHFFFAOYSA-N Diacetyl Chemical compound CC(=O)C(C)=O QSJXEFYPDANLFS-UHFFFAOYSA-N 0.000 claims description 10
- 239000002245 particle Substances 0.000 claims description 10
- 235000013305 food Nutrition 0.000 claims description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 9
- BVQVLAIMHVDZEL-UHFFFAOYSA-N 1-phenyl-1,2-propanedione Chemical compound CC(=O)C(=O)C1=CC=CC=C1 BVQVLAIMHVDZEL-UHFFFAOYSA-N 0.000 claims description 8
- 239000000203 mixture Substances 0.000 claims description 8
- 239000000463 material Substances 0.000 claims description 7
- 238000010828 elution Methods 0.000 claims description 6
- OGLCQHRZUSEXNB-WHDMSYDLSA-N (3r,3ar,5r,6r,6ar)-3,5,6-trihydroxy-hexahydrofuro[3,2-b]furan-2-one Chemical compound O[C@H]1C(=O)O[C@@H]2[C@@H](O)[C@H](O)O[C@@H]21 OGLCQHRZUSEXNB-WHDMSYDLSA-N 0.000 claims description 5
- 238000010438 heat treatment Methods 0.000 claims description 5
- 238000002552 multiple reaction monitoring Methods 0.000 claims description 5
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 3
- 238000001035 drying Methods 0.000 claims description 3
- 238000000132 electrospray ionisation Methods 0.000 claims description 3
- 239000000945 filler Substances 0.000 claims description 3
- 239000000741 silica gel Substances 0.000 claims description 3
- 229910002027 silica gel Inorganic materials 0.000 claims description 3
- RIGHPXPUHJFRHG-UHFFFAOYSA-N 2-chloro-2-phenylacetaldehyde Chemical compound O=CC(Cl)C1=CC=CC=C1 RIGHPXPUHJFRHG-UHFFFAOYSA-N 0.000 claims description 2
- 238000004807 desolvation Methods 0.000 claims description 2
- 238000000889 atomisation Methods 0.000 claims 1
- 230000035945 sensitivity Effects 0.000 abstract description 10
- 239000000047 product Substances 0.000 description 24
- 239000000523 sample Substances 0.000 description 16
- 150000002500 ions Chemical class 0.000 description 15
- 239000003814 drug Substances 0.000 description 10
- 230000000694 effects Effects 0.000 description 10
- 238000011084 recovery Methods 0.000 description 10
- 239000007853 buffer solution Substances 0.000 description 8
- 239000002609 medium Substances 0.000 description 8
- 241000411851 herbal medicine Species 0.000 description 7
- 238000011835 investigation Methods 0.000 description 7
- 239000006228 supernatant Substances 0.000 description 7
- 230000006907 apoptotic process Effects 0.000 description 6
- 238000010586 diagram Methods 0.000 description 6
- 238000002474 experimental method Methods 0.000 description 6
- 239000002207 metabolite Substances 0.000 description 6
- VLTRZXGMWDSKGL-UHFFFAOYSA-N perchloric acid Chemical compound OCl(=O)(=O)=O VLTRZXGMWDSKGL-UHFFFAOYSA-N 0.000 description 6
- 230000004044 response Effects 0.000 description 6
- 238000000926 separation method Methods 0.000 description 6
- 241000208341 Hedera Species 0.000 description 5
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 5
- 239000012154 double-distilled water Substances 0.000 description 5
- 210000001519 tissue Anatomy 0.000 description 5
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 4
- 244000184734 Pyrus japonica Species 0.000 description 4
- REFJWTPEDVJJIY-UHFFFAOYSA-N Quercetin Chemical compound C=1C(O)=CC(O)=C(C(C=2O)=O)C=1OC=2C1=CC=C(O)C(O)=C1 REFJWTPEDVJJIY-UHFFFAOYSA-N 0.000 description 4
- 239000007789 gas Substances 0.000 description 4
- 108010021182 gluconolactone oxidase Proteins 0.000 description 4
- 239000008103 glucose Substances 0.000 description 4
- 238000011534 incubation Methods 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- 238000004895 liquid chromatography mass spectrometry Methods 0.000 description 4
- 230000008569 process Effects 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- GEYOCULIXLDCMW-UHFFFAOYSA-N 1,2-phenylenediamine Chemical compound NC1=CC=CC=C1N GEYOCULIXLDCMW-UHFFFAOYSA-N 0.000 description 3
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
- 239000004475 Arginine Substances 0.000 description 3
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 3
- 108090000790 Enzymes Proteins 0.000 description 3
- 102000004190 Enzymes Human genes 0.000 description 3
- 241001671621 Hemarthria altissima Species 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- 230000018044 dehydration Effects 0.000 description 3
- 238000006297 dehydration reaction Methods 0.000 description 3
- 239000007924 injection Substances 0.000 description 3
- 238000002347 injection Methods 0.000 description 3
- 210000004379 membrane Anatomy 0.000 description 3
- 239000012528 membrane Substances 0.000 description 3
- VYQNWZOUAUKGHI-UHFFFAOYSA-N monobenzone Chemical compound C1=CC(O)=CC=C1OCC1=CC=CC=C1 VYQNWZOUAUKGHI-UHFFFAOYSA-N 0.000 description 3
- 238000007789 sealing Methods 0.000 description 3
- 239000012086 standard solution Substances 0.000 description 3
- IKHGUXGNUITLKF-UHFFFAOYSA-N Acetaldehyde Chemical compound CC=O IKHGUXGNUITLKF-UHFFFAOYSA-N 0.000 description 2
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 2
- 241000202726 Bupleurum Species 0.000 description 2
- 244000163122 Curcuma domestica Species 0.000 description 2
- 235000003392 Curcuma domestica Nutrition 0.000 description 2
- 241000893536 Epimedium Species 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 108010040476 FITC-annexin A5 Proteins 0.000 description 2
- 241000555712 Forsythia Species 0.000 description 2
- 244000153234 Hibiscus abelmoschus Species 0.000 description 2
- 241000132446 Inula Species 0.000 description 2
- 241001673966 Magnolia officinalis Species 0.000 description 2
- 241000756042 Polygonatum Species 0.000 description 2
- ZVOLCUVKHLEPEV-UHFFFAOYSA-N Quercetagetin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=C(O)C(O)=C(O)C=C2O1 ZVOLCUVKHLEPEV-UHFFFAOYSA-N 0.000 description 2
- 241000405911 Rehmannia glutinosa Species 0.000 description 2
- 244000299790 Rheum rhabarbarum Species 0.000 description 2
- 235000009411 Rheum rhabarbarum Nutrition 0.000 description 2
- HWTZYBCRDDUBJY-UHFFFAOYSA-N Rhynchosin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=CC(O)=C(O)C=C2O1 HWTZYBCRDDUBJY-UHFFFAOYSA-N 0.000 description 2
- 240000006079 Schisandra chinensis Species 0.000 description 2
- 235000008422 Schisandra chinensis Nutrition 0.000 description 2
- 102000004142 Trypsin Human genes 0.000 description 2
- 108090000631 Trypsin Proteins 0.000 description 2
- GZCGUPFRVQAUEE-SLPGGIOYSA-N aldehydo-D-glucose Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O GZCGUPFRVQAUEE-SLPGGIOYSA-N 0.000 description 2
- 239000010231 banlangen Substances 0.000 description 2
- 238000004113 cell culture Methods 0.000 description 2
- 239000006285 cell suspension Substances 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 239000012916 chromogenic reagent Substances 0.000 description 2
- 238000005336 cracking Methods 0.000 description 2
- 239000013078 crystal Substances 0.000 description 2
- 235000003373 curcuma longa Nutrition 0.000 description 2
- 238000007405 data analysis Methods 0.000 description 2
- 238000010790 dilution Methods 0.000 description 2
- 239000012895 dilution Substances 0.000 description 2
- 235000018905 epimedium Nutrition 0.000 description 2
- 239000012091 fetal bovine serum Substances 0.000 description 2
- 238000013467 fragmentation Methods 0.000 description 2
- 238000006062 fragmentation reaction Methods 0.000 description 2
- 239000001963 growth medium Substances 0.000 description 2
- 238000007689 inspection Methods 0.000 description 2
- 238000000752 ionisation method Methods 0.000 description 2
- MWDZOUNAPSSOEL-UHFFFAOYSA-N kaempferol Natural products OC1=C(C(=O)c2cc(O)cc(O)c2O1)c3ccc(O)cc3 MWDZOUNAPSSOEL-UHFFFAOYSA-N 0.000 description 2
- 238000002372 labelling Methods 0.000 description 2
- 238000012417 linear regression Methods 0.000 description 2
- 230000014759 maintenance of location Effects 0.000 description 2
- 239000011159 matrix material Substances 0.000 description 2
- 230000002503 metabolic effect Effects 0.000 description 2
- 239000010413 mother solution Substances 0.000 description 2
- OJUGVDODNPJEEC-UHFFFAOYSA-N phenylglyoxal Chemical compound O=CC(=O)C1=CC=CC=C1 OJUGVDODNPJEEC-UHFFFAOYSA-N 0.000 description 2
- 239000002243 precursor Substances 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 238000011002 quantification Methods 0.000 description 2
- 235000005875 quercetin Nutrition 0.000 description 2
- 229960001285 quercetin Drugs 0.000 description 2
- 238000000581 reactive spray deposition Methods 0.000 description 2
- 230000009257 reactivity Effects 0.000 description 2
- 101150041393 rsd gene Proteins 0.000 description 2
- 238000001228 spectrum Methods 0.000 description 2
- 238000010183 spectrum analysis Methods 0.000 description 2
- 239000012089 stop solution Substances 0.000 description 2
- 230000001988 toxicity Effects 0.000 description 2
- 231100000419 toxicity Toxicity 0.000 description 2
- 238000012546 transfer Methods 0.000 description 2
- 239000012588 trypsin Substances 0.000 description 2
- 235000013976 turmeric Nutrition 0.000 description 2
- 238000012795 verification Methods 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- VEPOHXYIFQMVHW-XOZOLZJESA-N 2,3-dihydroxybutanedioic acid (2S,3S)-3,4-dimethyl-2-phenylmorpholine Chemical compound OC(C(O)C(O)=O)C(O)=O.C[C@H]1[C@@H](OCCN1C)c1ccccc1 VEPOHXYIFQMVHW-XOZOLZJESA-N 0.000 description 1
- 244000025254 Cannabis sativa Species 0.000 description 1
- 241000132536 Cirsium Species 0.000 description 1
- 241000756943 Codonopsis Species 0.000 description 1
- 235000021508 Coleus Nutrition 0.000 description 1
- 244000061182 Coleus blumei Species 0.000 description 1
- 238000002965 ELISA Methods 0.000 description 1
- 238000008157 ELISA kit Methods 0.000 description 1
- 241001079251 Euodia Species 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 1
- 241001261543 Orthriophis moellendorffi Species 0.000 description 1
- PCNDJXKNXGMECE-UHFFFAOYSA-N Phenazine Natural products C1=CC=CC2=NC3=CC=CC=C3N=C21 PCNDJXKNXGMECE-UHFFFAOYSA-N 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- CKUAXEQHGKSLHN-UHFFFAOYSA-N [C].[N] Chemical compound [C].[N] CKUAXEQHGKSLHN-UHFFFAOYSA-N 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 238000012742 biochemical analysis Methods 0.000 description 1
- 239000012472 biological sample Substances 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 230000010261 cell growth Effects 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 238000003776 cleavage reaction Methods 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 239000008358 core component Substances 0.000 description 1
- 230000002596 correlated effect Effects 0.000 description 1
- 230000007797 corrosion Effects 0.000 description 1
- 238000005260 corrosion Methods 0.000 description 1
- 238000005138 cryopreservation Methods 0.000 description 1
- 239000012228 culture supernatant Substances 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 238000009795 derivation Methods 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 125000004989 dicarbonyl group Chemical group 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 230000006806 disease prevention Effects 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 238000000684 flow cytometry Methods 0.000 description 1
- 230000004153 glucose metabolism Effects 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- ZRALSGWEFCBTJO-UHFFFAOYSA-N guanidine group Chemical group NC(=N)N ZRALSGWEFCBTJO-UHFFFAOYSA-N 0.000 description 1
- 235000004280 healthy diet Nutrition 0.000 description 1
- 150000002402 hexoses Chemical class 0.000 description 1
- 125000002883 imidazolyl group Chemical group 0.000 description 1
- 239000000543 intermediate Substances 0.000 description 1
- 230000031700 light absorption Effects 0.000 description 1
- 238000001819 mass spectrum Methods 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 229910000403 monosodium phosphate Inorganic materials 0.000 description 1
- 235000019799 monosodium phosphate Nutrition 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- YTJSFYQNRXLOIC-UHFFFAOYSA-N octadecylsilane Chemical group CCCCCCCCCCCCCCCCCC[SiH3] YTJSFYQNRXLOIC-UHFFFAOYSA-N 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 238000010979 pH adjustment Methods 0.000 description 1
- 239000008188 pellet Substances 0.000 description 1
- 229960005222 phenazone Drugs 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 238000007747 plating Methods 0.000 description 1
- 238000006116 polymerization reaction Methods 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- XJMOSONTPMZWPB-UHFFFAOYSA-M propidium iodide Chemical compound [I-].[I-].C12=CC(N)=CC=C2C2=CC=C(N)C=C2[N+](CCC[N+](C)(CC)CC)=C1C1=CC=CC=C1 XJMOSONTPMZWPB-UHFFFAOYSA-M 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 238000004445 quantitative analysis Methods 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 230000007017 scission Effects 0.000 description 1
- AJPJDKMHJJGVTQ-UHFFFAOYSA-M sodium dihydrogen phosphate Chemical compound [Na+].OP(O)([O-])=O AJPJDKMHJJGVTQ-UHFFFAOYSA-M 0.000 description 1
- 238000000527 sonication Methods 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 150000003462 sulfoxides Chemical class 0.000 description 1
- 125000005555 sulfoximide group Chemical group 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 230000002277 temperature effect Effects 0.000 description 1
- 230000001550 time effect Effects 0.000 description 1
- 238000010200 validation analysis Methods 0.000 description 1
- 230000035899 viability Effects 0.000 description 1
- -1 vortex for 5 min Substances 0.000 description 1
- 239000008433 xiaoji Substances 0.000 description 1
Images
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
- G01N30/04—Preparation or injection of sample to be analysed
- G01N30/06—Preparation
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
- G01N30/26—Conditioning of the fluid carrier; Flow patterns
- G01N30/28—Control of physical parameters of the fluid carrier
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
- G01N30/26—Conditioning of the fluid carrier; Flow patterns
- G01N30/28—Control of physical parameters of the fluid carrier
- G01N30/30—Control of physical parameters of the fluid carrier of temperature
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
- G01N30/26—Conditioning of the fluid carrier; Flow patterns
- G01N30/28—Control of physical parameters of the fluid carrier
- G01N30/32—Control of physical parameters of the fluid carrier of pressure or speed
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
- G01N30/62—Detectors specially adapted therefor
- G01N30/72—Mass spectrometers
Landscapes
- Physics & Mathematics (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Immunology (AREA)
- Pathology (AREA)
- Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
Abstract
Description
技术领域technical field
本发明涉及生物化学分析领域,特别是涉及一种α-二羰基化合物的检测方法及其应用。The invention relates to the field of biochemical analysis, in particular to a method for detecting an α-dicarbonyl compound and its application.
背景技术Background technique
α-二羰基化合物是一类主要来自食物热加工和机体糖代谢过程产生的活泼中间体和反应性代谢物。这类物质能对蛋白质、DNA等体内重要生命物质进行化学修饰,导致其结构改变和功能损害,从而引起衰老或糖尿病等多种疾病,在食品安全和生物医学领域日益引发关注。因此,如何检测这类潜在危害物在食物和生物样品中的种类、含量和变化,对健康饮食和防治疾病具有重要意义。α-Dicarbonyl compounds are a class of active intermediates and reactive metabolites mainly from food thermal processing and glucose metabolism in the body. Such substances can chemically modify proteins, DNA and other important life substances in the body, resulting in structural changes and functional damages, thereby causing various diseases such as aging or diabetes, which are increasingly attracting attention in the fields of food safety and biomedicine. Therefore, how to detect the types, contents and changes of such potential hazards in food and biological samples is of great significance for healthy diet and disease prevention.
α-二羰基化合物具有强亲水性,且稳定性较低、缺少紫外吸收基团及荧光发色基团,同时包含α-二羰基化合物的实际样品基质成分往往较为复杂,最终造成无法对其进行精准检测。因此,α-二羰基化合物需要经前处理方可进行分析,通过借助一些化合物对α-二羰基化合物进行衍生化,从而改善该类物质的色谱保留、增加光学基团,实现对其的分离、定性及定量。α-dicarbonyl compounds have strong hydrophilicity, low stability, lack of ultraviolet absorbing groups and fluorescent chromophores, and the actual sample matrix composition containing α-dicarbonyl compounds is often complicated, which ultimately makes it impossible to analyze them. Accurate detection. Therefore, α-dicarbonyl compounds need to be pretreated before they can be analyzed. By derivatizing α-dicarbonyl compounds with some compounds, the chromatographic retention of such substances can be improved, and optical groups can be added to achieve their separation, Qualitative and quantitative.
传统的α-二羰基化合物衍生剂多为邻二胺化合物,其中邻苯二胺最为普遍。邻苯二胺具有衍生快、产生发色团、廉价易得等优点,在色谱方法柱前衍生上应用较广。但是,其本身难以保存,在室温下不稳定,易氧化为吩嗪,并且还具有一定的生物毒性,会造成对皮肤、黏膜等的腐蚀。Traditional α-dicarbonyl compound derivatives are mostly o-diamine compounds, of which o-phenylenediamine is the most common. O-phenylenediamine has the advantages of fast derivatization, chromophore generation, cheap and easy availability, and is widely used in pre-column derivatization of chromatographic methods. However, it is difficult to store, unstable at room temperature, easily oxidized to phenazine, and has certain biological toxicity, which can cause corrosion to skin, mucous membranes, etc.
含胍基反应基团的精氨酸也是一种传统的α-二羰基化合物衍生剂,其优势在于生物毒性小、选择性佳,适用于基质复杂的样品的测定。然而,精氨酸极性较大,色谱保留差。Arginine containing a guanidine reactive group is also a traditional α-dicarbonyl compound derivatizing agent, which has the advantages of low biological toxicity and good selectivity, and is suitable for the determination of samples with complex matrices. However, arginine is more polar and has poor chromatographic retention.
还有的传统α-二羰基化合物衍生剂对α-二羰基化合物进行衍生化反应后应用于色谱质谱联用分析中,会出现灵敏度低的问题,这是因为α-二羰基类化合物不同的物质间分子量差异大,长链α-二羰基化合物保留己糖C6的结构,但是短链α-二羰基化合物结构简单、分子量小,导致二者在挥发性方面存在较大差别。There are also traditional α-dicarbonyl compound derivatizing agents that derivatize α-dicarbonyl compounds and then apply them to chromatographic mass spectrometry analysis, which will have the problem of low sensitivity. This is because α-dicarbonyl compounds are different substances. The difference in molecular weight is large, the long-chain α-dicarbonyl compound retains the structure of hexose C6, but the short-chain α-dicarbonyl compound has a simple structure and small molecular weight, resulting in a big difference in volatility between the two.
发明内容SUMMARY OF THE INVENTION
基于此,本发明提供了一种α-二羰基化合物的检测方法,所采用的试剂与衍生化物的性质均稳定,灵敏度高,检测范围广,且重复性与专一性均较好。Based on this, the present invention provides a detection method for an α-dicarbonyl compound, which adopts the reagents and derivatives with stable properties, high sensitivity, wide detection range, and good repeatability and specificity.
本发明通过如下技术方案实现。The present invention is realized through the following technical solutions.
一种α-二羰基化合物的检测方法,包括如下步骤:A method for detecting an α-dicarbonyl compound, comprising the steps:
将2-胍基苯并咪唑与溶剂混合,制备衍生化试剂;Mix 2-guanidinobenzimidazole with solvent to prepare derivatization reagent;
将待测样品与所述衍生化试剂混合,进行衍生化反应,制备衍生化产物;Mixing the sample to be tested with the derivatization reagent to carry out a derivatization reaction to prepare a derivatized product;
将所述衍生化产物进行液相色谱串联质谱分析;performing liquid chromatography tandem mass spectrometry analysis on the derivatized product;
其中,所述液相色谱采用的条件包括:流动相A为甲酸水溶液;流动相B为甲醇。Wherein, the conditions adopted by the liquid chromatography include: mobile phase A is formic acid aqueous solution; mobile phase B is methanol.
在其中一个实施例中,衍生化反应的温度为30℃~50℃;和/或In one embodiment, the temperature of the derivatization reaction is 30°C to 50°C; and/or
衍生化反应的时间为6h~12h;和/或The time of the derivatization reaction is 6h~12h; and/or
衍生化反应在pH为7~8的环境中进行。The derivatization reaction is carried out in an environment of pH 7-8.
在其中一个实施例中,所述液相色谱采用的条件还包括:采用梯度洗脱程序,所述梯度洗脱程序包括:0min~6min,流动相B的体积百分数为10%;6min~10min,流动相B的体积百分数从10%变化至20%;10min~16min,流动相B的体积百分数从20%变化至90%;16min~24min,流动相B的体积百分数保持为90%;24min~25min,流动相B的体积百分数从90%变化至10%。In one embodiment, the conditions used in the liquid chromatography further include: using a gradient elution program, the gradient elution program includes: 0 min to 6 min, the volume percentage of mobile phase B is 10%; 6 min to 10 min, The volume percentage of mobile phase B changes from 10% to 20%; 10min~16min, the volume percentage of mobile phase B changes from 20% to 90%; 16min~24min, the volume percentage of mobile phase B remains at 90%; 24min~25min , the volume percentage of mobile phase B was varied from 90% to 10%.
在其中一个实施例中,所述液相色谱采用的条件还包括:流速为0.8mL/min~1.2mL/min;柱温为20℃~25℃;色谱柱为十八烷基硅烷键合硅胶柱;和/或In one embodiment, the conditions used in the liquid chromatography further include: the flow rate is 0.8mL/min~1.2mL/min; the column temperature is 20℃~25℃; the chromatographic column is octadecylsilane bonded silica gel column; and/or
所述液相色谱采用的色谱柱的尺寸包括:柱长为120mm~130mm,内径为4.4mm~4.8mm,填料粒径为4μm~6μm。The size of the chromatographic column used in the liquid chromatography includes: the column length is 120 mm-130 mm, the inner diameter is 4.4 mm-4.8 mm, and the particle size of the filler is 4 μm-6 μm.
在其中一个实施例中,所述甲酸水溶液中,甲酸的质量分数为0.08%~0.12%。In one embodiment, the mass fraction of formic acid in the aqueous formic acid solution is 0.08% to 0.12%.
在其中一个实施例中,所述质谱采用的条件包括:离子化方式为电喷雾电离;雾化气流速为2L/min~4L/min;干燥气流速为8L/min~12L/min;脱溶剂管温度为220℃~280℃;加热模块温度为350℃~450℃;离子源接口电压为3.5kV~4.5kV;扫描模式为多反应监测扫描。In one embodiment, the conditions used in the mass spectrometry include: the ionization method is electrospray ionization; the flow rate of the atomizing gas is 2L/min-4L/min; the flow rate of the drying gas is 8L/min-12L/min; The tube temperature is 220°C to 280°C; the heating module temperature is 350°C to 450°C; the ion source interface voltage is 3.5kV to 4.5kV; the scanning mode is multiple reaction monitoring scanning.
在其中一个实施例中,所述溶剂选自甲醇与水中的一种或两种。In one embodiment, the solvent is selected from one or both of methanol and water.
在其中一个实施例中,所述α-二羰基化合物选自乙二醛、甲基乙二醛、2,3-丁二酮、D-葡糖醛酮、2-氯代-2-苯基乙醛与1-苯基-1,2-丙二酮中的一种或几种。In one embodiment, the α-dicarbonyl compound is selected from glyoxal, methylglyoxal, 2,3-butanedione, D-glucurone, 2-chloro-2-phenyl One or more of acetaldehyde and 1-phenyl-1,2-propanedione.
在其中一个实施例中,所述待测样品的来源选自中药材、生物组织与食品中的一种或几种。In one embodiment, the source of the sample to be tested is selected from one or more of Chinese medicinal materials, biological tissues and food.
本发明还提供一种如上所述的α-二羰基化合物的检测方法在检测中药材、生物组织与食品中α-二羰基化合物中的应用。The present invention also provides an application of the above-mentioned method for detecting α-dicarbonyl compounds in detecting α-dicarbonyl compounds in Chinese medicinal materials, biological tissues and foods.
与现有技术相比较,本发明的α-二羰基化合物的检测方法具有如下有益效果:Compared with the prior art, the detection method of the α-dicarbonyl compound of the present invention has the following beneficial effects:
本发明人选用2-胍基苯并咪唑作为α-二羰基化合物的衍生试剂,并将衍生化后的产物进行液相色谱串联质谱分析,建立了一个以2-胍基苯并咪唑为质谱增敏探针的α-二羰基化合物衍生方法。2-胍基苯并咪唑作为电子供体,易进攻α-二羰基结构,从而形成结构较稳定的五元环,最终实现衍生化目的,提高离子化效率与质谱响应,能够获得较好的灵敏度,具体体现为短链α-二羰基化合物的检测灵敏度提高15-65倍。同时本发明的α-二羰基化合物的检测方法检测范围广,能够同时满足长链和短链的α-二羰基化合物的检测,并且重复性好,准确性高,专一性与选择性也较好。The inventors selected 2-guanidinobenzimidazole as a derivatizing reagent for α-dicarbonyl compounds, and analyzed the derivatized products by liquid chromatography tandem mass spectrometry, and established a new method using 2-guanidinobenzimidazole as a mass spectrometer Derivatization of α-dicarbonyl compounds of sensitive probes. As an electron donor, 2-guanidinobenzimidazole can easily attack the α-dicarbonyl structure, thereby forming a five-membered ring with a relatively stable structure, and finally achieve the purpose of derivatization, improve the ionization efficiency and mass spectrometry response, and can obtain better sensitivity , which is embodied in that the detection sensitivity of short-chain α-dicarbonyl compounds is increased by 15-65 times. At the same time, the detection method for α-dicarbonyl compounds of the present invention has a wide detection range, can meet the detection of long-chain and short-chain α-dicarbonyl compounds at the same time, and has good repeatability, high accuracy, and relatively high specificity and selectivity. it is good.
附图说明Description of drawings
图1为本发明提供的不同衍生化温度效果考察对比图;Fig. 1 is the different derivatization temperature effect investigation contrast diagram provided by the present invention;
图2为本发明提供的不同衍生化温度下未脱水与脱水产物对比图;Fig. 2 is not dehydration and dehydration product contrast diagram under different derivatization temperatures provided by the present invention;
图3为本发明提供的不同衍生化时间效果考察对比图;Fig. 3 is the different derivatization time effect investigation contrast diagram provided by the present invention;
图4为本发明提供的不同衍生化pH效果考察对比图;Fig. 4 is a comparison diagram of different derivatization pH effects provided by the present invention;
图5为本发明提供的不同色谱柱效果考察对比图;Fig. 5 is a comparison diagram of different chromatographic column effects provided by the present invention;
图6为本发明提供的2-GBI-GO的二级质谱裂解图;Fig. 6 is the secondary mass spectrometry fragmentation diagram of 2-GBI-GO provided by the present invention;
图7为本发明提供的各衍生化产物子离子谱图;Fig. 7 is each derivatization product product ion spectrogram provided by the present invention;
图8为本发明提供的各衍生化产物的稳定性考察图。Fig. 8 is a graph showing the stability of each derivatized product provided by the present invention.
具体实施方式Detailed ways
为了便于理解本发明,下面将参照相关附图对本发明进行更全面的描述。附图中给出了本发明的较佳实施方式。但是,本发明可以以许多不同的形式来实现,并不限于本文所描述的实施方式。相反地,提供这些实施方式的目的是使对本发明的公开内容的理解更加透彻全面。In order to facilitate understanding of the present invention, the present invention will be described more fully hereinafter with reference to the related drawings. The preferred embodiments of the invention are shown in the accompanying drawings. However, the present invention may be embodied in many different forms and is not limited to the embodiments described herein. Rather, these embodiments are provided so that a thorough and complete understanding of the present disclosure is provided.
除非另有定义,本文所使用的所有的技术和科学术语与属于本发明的技术领域的技术人员通常理解的含义相同。本文中在本发明的说明书中所使用的术语只是为了描述具体的实施方式的目的,不是旨在于限制本发明。本文所使用的术语“和/或”包括一个或多个相关的所列项目的任意的和所有的组合。Unless otherwise defined, all technical and scientific terms used herein have the same meaning as commonly understood by one of ordinary skill in the art to which this invention belongs. The terms used herein in the description of the present invention are for the purpose of describing specific embodiments only, and are not intended to limit the present invention. As used herein, the term "and/or" includes any and all combinations of one or more of the associated listed items.
本发明提供了一种α-二羰基化合物的检测方法,包括如下步骤:The invention provides a method for detecting an α-dicarbonyl compound, comprising the following steps:
将2-胍基苯并咪唑与溶剂混合,制备衍生化试剂;Mix 2-guanidinobenzimidazole with solvent to prepare derivatization reagent;
将待测样品与衍生化试剂混合,进行衍生化反应,制备衍生化产物;Mix the sample to be tested with the derivatization reagent, carry out a derivatization reaction, and prepare a derivatized product;
将衍生化产物进行液相色谱串联质谱分析;The derivatized product is analyzed by liquid chromatography tandem mass spectrometry;
其中,液相色谱采用的条件包括:流动相A为甲酸水溶液;流动相B为甲醇。Wherein, the conditions adopted by the liquid chromatography include: mobile phase A is formic acid aqueous solution; mobile phase B is methanol.
在一个具体的示例中,衍生化反应的温度为30℃~50℃。优选地,衍生化反应的温度为40℃。In a specific example, the temperature of the derivatization reaction is 30°C to 50°C. Preferably, the temperature of the derivatization reaction is 40°C.
在一个具体的示例中,衍生化反应的时间为6h~12h。优选地,衍生化反应的时间为6h。In a specific example, the time for the derivatization reaction is 6 h to 12 h. Preferably, the time for the derivatization reaction is 6h.
在一个具体的示例中,衍生化反应在pH为7~8的环境中进行。优选地,衍生化反应在pH为7.4的环境中进行。更具体地,pH调节通过PBS缓冲溶液的添加实现。In a specific example, the derivatization reaction is carried out in an environment of pH 7-8. Preferably, the derivatization reaction is carried out in an environment of pH 7.4. More specifically, pH adjustment was achieved by the addition of PBS buffer solution.
在一个具体的示例中,液相色谱采用的条件还包括:采用梯度洗脱程序,梯度洗脱程序包括:0min~6min,流动相B的体积百分数为10%;6min~10min,流动相B的体积百分数从10%变化至20%;10min~16min,流动相B的体积百分数从20%变化至90%;16min~24min,流动相B的体积百分数保持为90%;24min~25min,流动相B的体积百分数从90%变化至10%。In a specific example, the conditions used in the liquid chromatography further include: using a gradient elution program, the gradient elution program includes: 0min-6min, the volume percentage of the mobile phase B is 10%; 6min-10min, the mobile phase B Volume percentage changed from 10% to 20%; 10min~16min, the volume percentage of mobile phase B changed from 20% to 90%; 16min~24min, the volume percentage of mobile phase B remained at 90%; 24min~25min, mobile phase B The volume percentage of 90% to 10%.
在一个具体的示例中,液相色谱采用的条件还包括:流速为0.8mL/min~1.2mL/min;色谱柱为十八烷基硅烷键合硅胶柱;柱温为20℃~25℃。In a specific example, the conditions used in the liquid chromatography further include: the flow rate is 0.8mL/min-1.2mL/min; the chromatographic column is an octadecylsilane-bonded silica gel column; and the column temperature is 20°C to 25°C.
在一个具体的示例中,液相色谱采用的色谱柱的尺寸包括:柱长为120mm~130mm,内径为4.4mm~4.8mm,填料粒径为4μm~6μm。In a specific example, the size of the chromatographic column used in liquid chromatography includes: the column length is 120 mm-130 mm, the inner diameter is 4.4 mm-4.8 mm, and the particle size of the filler is 4 μm-6 μm.
更具体地,液相色谱采用的色谱柱为ΜLtimate XB-C18(125mm×4.6mm,粒径5μM)。More specifically, the column used for liquid chromatography was MLtimate XB-C18 (125 mm×4.6 mm, particle size 5 μM).
在一个具体的示例中,甲酸水溶液中,甲酸的质量分数为0.08%~0.12%。In a specific example, in the aqueous formic acid solution, the mass fraction of formic acid is 0.08% to 0.12%.
更具体地,甲酸水溶液中,甲酸的质量分数0.1%。More specifically, in the formic acid aqueous solution, the mass fraction of formic acid is 0.1%.
在一个具体的示例中,质谱采用的条件包括:离子化方式为电喷雾电离;雾化气流速为2L/min~4L/min;干燥气流速为8L/min~12L/min;脱溶剂管温度为220℃~280℃;加热模块温度为350℃~450℃;离子源接口电压为3.5kV~4.5kV;扫描模式为多反应监测扫描。In a specific example, the conditions used in mass spectrometry include: the ionization method is electrospray ionization; the flow rate of the atomizing gas is 2L/min-4L/min; the flow rate of the drying gas is 8L/min-12L/min; the temperature of the desolvation tube The temperature is 220℃~280℃; the temperature of the heating module is 350℃~450℃; the ion source interface voltage is 3.5kV~4.5kV; the scanning mode is multiple reaction monitoring scanning.
在一个具体的示例中,溶剂选自甲醇与水中的一种或两种。In a specific example, the solvent is selected from one or both of methanol and water.
在一个具体的示例中,α-二羰基化合物选自乙二醛、甲基乙二醛、2,3-丁二酮、D-葡糖醛酮、2-氯代-2-苯基乙醛与1-苯基-1,2-丙二酮中的一种或几种。In a specific example, the α-dicarbonyl compound is selected from the group consisting of glyoxal, methylglyoxal, 2,3-butanedione, D-glucurone, 2-chloro-2-phenylacetaldehyde One or more of 1-phenyl-1,2-propanedione.
在一个具体的示例中,待测样品的来源选自中药材、生物组织与食品中的一种或几种。In a specific example, the source of the sample to be tested is selected from one or more of Chinese medicinal materials, biological tissues and food.
在一个具体的示例中,中药材选自乌药、厚朴、玉竹、醉鱼草叶、络石藤、补骨脂、柴胡、五味子、吴茱萸、白花蛇草、郁金、淫羊藿、川芎、小蓟、旋覆花、大黄、连翘、生地黄、板蓝根、续断与党参中的一种或多种。In a specific example, the Chinese herbal medicine is selected from the group consisting of black medicine, Magnolia officinalis, Polygonatum japonica, A. chinensis, A. chinensis, Psoraleae, Bupleurum, Schisandra japonica, Evodia Fructus, Hentai Radix, Turmeric, Epimedium One or more of , Chuanxiong, Xiaoji, Inula, Rhubarb, Forsythia, Rehmannia glutinosa, Radix Isatidis, Dangshen and Codonopsis.
在一个具体的示例中,生物组织为细胞。更具体地,细胞选自HEK 293细胞。In a specific example, the biological tissue is a cell. More specifically, the cells are selected from HEK 293 cells.
本发明还提供一种上述的α-二羰基化合物的检测方法在检测中药材、生物组织与食品中α-二羰基化合物中的应用。The present invention also provides an application of the above-mentioned detection method for α-dicarbonyl compounds in detecting α-dicarbonyl compounds in Chinese medicinal materials, biological tissues and foods.
本发明提供的α-二羰基化合物的检测方法所获得的各衍生化产物的裂解具有类似的规律。这一规律不仅能够准确判断衍生化反应是否真正发生,还能方便后续解谱与数据分析。并且形成了共同的子离子m/z 159.0与m/z 134.0,可根据这一特性利用前体离子扫描模式对非目标性反应性代谢物α-二羰基化合物进行筛查,拓展代谢谱。The cleavage of each derivatized product obtained by the detection method of α-dicarbonyl compound provided by the present invention has a similar rule. This rule can not only accurately judge whether the derivatization reaction really occurs, but also facilitate the subsequent spectrum analysis and data analysis. And the common product ions m/z 159.0 and m/z 134.0 are formed. According to this characteristic, the precursor ion scanning mode can be used to screen the non-target reactive metabolite α-dicarbonyl compounds to expand the metabolic spectrum.
以下结合具体实施例对本发明的α-二羰基化合物的检测方法及其应用做进一步详细的说明。以下实施例中所用的原料,如无特别说明,均为市售产品。The detection method and application of the α-dicarbonyl compound of the present invention will be further described in detail below with reference to specific examples. The raw materials used in the following examples, unless otherwise specified, are all commercially available products.
实施例1Example 1
本实施例提供一种α-二羰基化合物的检测方法,具体如下:The present embodiment provides a method for detecting an α-dicarbonyl compound, which is specifically as follows:
一、试剂1. Reagents
2-胍基苯并咪唑(2-GBI)、乙二醛(GO)、甲基乙二醛(MGO)、2,3-丁二酮(DA)、邻苯二胺、精氨酸均购于辽宁库克生物技术有限公司;D-葡糖醛酮(GS)、2-胍基苯并咪唑均购自Sigma公司(上海,中国);2-氧代-2-苯基乙醛(2-OPT)、1-苯基-1,2-丙二酮(1-PPD)均购于北京伊诺凯科技有限公司;磷酸氢二钠、磷酸二氢钠、氢氧化钠均购于阿拉丁生化科技股份有限公司;甲醇均购于伊诺凯科技有限公司;甲酸购于天津市科密欧化学试剂有限公司。2-guanidinobenzimidazole (2-GBI), glyoxal (GO), methylglyoxal (MGO), 2,3-butanedione (DA), o-phenylenediamine, arginine were all purchased from Liaoning Cook Biotechnology Co., Ltd.; D-Glucurone (GS) and 2-guanidinobenzimidazole were purchased from Sigma Company (Shanghai, China); 2-oxo-2-phenylacetaldehyde (2 -OPT), 1-phenyl-1,2-propanedione (1-PPD) were purchased from Beijing Inoke Technology Co., Ltd.; disodium hydrogen phosphate, sodium dihydrogen phosphate and sodium hydroxide were purchased from Aladdin Biochemical Technology Co., Ltd.; methanol was purchased from Inokai Technology Co., Ltd.; formic acid was purchased from Tianjin Kemeiou Chemical Reagent Co., Ltd.
二、实验过程Second, the experimental process
1、衍生化反应1. Derivatization reaction
胍基苯并咪唑溶液的制备:准确称取2-GBI标准品,用甲醇(色谱级)或ddH2O溶解、稀释,得10mM各标准品母液,放置-20℃避光保存。Preparation of guanidinobenzimidazole solution: Accurately weigh 2-GBI standard product, dissolve and dilute with methanol (chromatographic grade) or ddH2O to obtain 10mM mother solution of each standard product, and store at -20°C in the dark.
反应在1.5mL离心管中进行,反应液总体积为1mL。按表1依次加入2-胍基苯并咪唑溶液、PBS缓冲溶液、α-二羰基化合物,涡旋2min。在40℃水浴加热条件以及pH为7.4的条件下反应6h后,置于-20℃条件下20min,以终止反应。过0.22μm滤膜,以供LC-MS/MS检测分析。保证至少三个平行样。The reaction was carried out in a 1.5 mL centrifuge tube, and the total volume of the reaction solution was 1 mL. Add 2-guanidinobenzimidazole solution, PBS buffer solution and α-dicarbonyl compound in sequence according to Table 1, and vortex for 2min. After reacting for 6 h under the condition of 40°C water bath heating and pH 7.4, it was placed at -20°C for 20 min to terminate the reaction. Passed through a 0.22 μm filter for LC-MS/MS detection and analysis. Ensure at least three parallel samples.
表1Table 1
注:除PBS外,浓度均为10μM。NOTE: Except for PBS, the concentration is 10 μM.
2、液相色谱-质谱检测分析2. Liquid chromatography-mass spectrometry detection and analysis
(1)液相色谱条件如下:(1) Liquid chromatography conditions are as follows:
分析仪器:三重四极杆液质联用仪(岛津,LC-MS 8050);Analytical instrument: triple quadrupole liquid mass spectrometer (Shimadzu, LC-MS 8050);
色谱柱:ΜLtimate XB-C18(125mm×4.6mm,粒径5μM);Chromatographic column: MLtimate XB-C18 (125mm×4.6mm, particle size 5μM);
流动相A:含0.1%甲酸的水溶液(v/v);Mobile phase A: 0.1% formic acid in water (v/v);
流动相B:甲醇;Mobile phase B: methanol;
流速:1mL/min;Flow rate: 1mL/min;
进样体积:10μL;Injection volume: 10 μL;
洗脱方式:梯度洗脱(洗脱程序如表2所示);Elution mode: gradient elution (the elution program is shown in Table 2);
柱温:22℃。Column temperature: 22°C.
表2Table 2
(2)质谱条件如表3所示,采用正离子模式分析:(2) The mass spectrometry conditions are shown in Table 3, and the positive ion mode is used to analyze:
表3table 3
3、改变条件3. Change the conditions
(1)其他条件不变,仅改变衍生温度:将40℃分别改成24℃、37℃、60℃与80℃;(1) Other conditions remain unchanged, only the derivative temperature is changed: 40°C is changed to 24°C, 37°C, 60°C and 80°C respectively;
(2)其他条件不变,仅改变衍生时间:将6h分别改成2h、4h、12h与24h。(2) Other conditions remain unchanged, only the derivation time is changed: 6h is changed to 2h, 4h, 12h and 24h respectively.
(3)其他条件不变,仅改变衍生pH:通过PBS缓冲溶液在pH为3~10范围内进行调节。(3) Other conditions remain unchanged, only the derivatization pH is changed: adjust the pH in the range of 3-10 by PBS buffer solution.
(4)其他条件不变,仅改变色谱柱的型号:将ΜLtimate XB-C18柱(125mm×4.6mm,粒径5μM)改为Diamonsil C18柱(150×2.1mm,粒径3μM)。(4) Other conditions remain unchanged, only the type of chromatographic column is changed: MLtimate XB-C18 column (125mm×4.6mm, particle size 5μM) is changed to Diamonsil C18 column (150×2.1mm, particle size 3μM).
三、实验结果3. Experimental results
1、条件筛选1. Conditional filter
(1)分别选取24、37、40、60、80℃对不同α-二羰基化合物的衍生效果进行考察,实验结果如图1。在保证变量单一的情况下,发现六种α-二羰基化合物中MGO的衍生化强度最好,其次是GO、DA等短链二羰基化合物,1-PPD、2-OPT、GS的衍生化强度依次减弱。这是因为在理论上乙二醛的反应活性最高,但实际上乙二醛在水溶液中聚合成都较高,因此甲基乙二醛的反应性最好。此外,乙二醛、甲基乙二醛的最适衍生化温度均为40℃,其他四个α-二羰基化合物的都为24℃。但除2,3-丁二酮外,剩余三个α-二羰基化合物的从24℃至40℃的响应变化均在可接受范围内。所以,选取40℃作为衍生化反应温度。(1) 24, 37, 40, 60, and 80 °C were selected to investigate the derivatization effects of different α-dicarbonyl compounds. The experimental results are shown in Figure 1. Under the condition of ensuring a single variable, it is found that MGO has the best derivatization strength among the six α-dicarbonyl compounds, followed by short-chain dicarbonyl compounds such as GO and DA, and the derivatization strength of 1-PPD, 2-OPT, and GS. weakened sequentially. This is because in theory glyoxal has the highest reactivity, but in practice glyoxal has a higher degree of polymerization in aqueous solution, so methylglyoxal has the best reactivity. In addition, the optimum derivatization temperatures of glyoxal and methylglyoxal were both 40°C, and the other four α-dicarbonyl compounds were all 24°C. But except for 2,3-butanedione, the response changes from 24°C to 40°C for the remaining three α-dicarbonyl compounds were all within the acceptable range. Therefore, 40°C was chosen as the derivatization reaction temperature.
实验过程中发现衍生化温度越高,反应液颜色越深,60℃时其溶液颜色呈黄色,80℃时呈棕色。同时,对衍生化产物(未脱水)与副产物(脱水)进行监测,以2-GBI-GO为例,发现温度升高,仅少部分衍生化产物未进一步脱水,如图2。结合该实验现象推测,在其衍生化温度超过一定界限时,易引起衍生化物变性,从而导致衍生化效果的大幅下降。During the experiment, it was found that the higher the derivatization temperature, the darker the color of the reaction solution. The color of the solution was yellow at 60°C and brown at 80°C. At the same time, the derivatization products (not dehydrated) and by-products (dehydration) were monitored. Taking 2-GBI-GO as an example, it was found that only a small part of the derivatized products were not dehydrated further as the temperature increased, as shown in Figure 2. Combined with this experimental phenomenon, it is speculated that when the derivatization temperature exceeds a certain limit, the derivatization is likely to be denatured, resulting in a significant decrease in the derivatization effect.
(2)保证变量单一,以小时为单位连续反应24h,选取五个时间点(2、4、6、12、24h)进行考察。可以从图3中得出GO、MGO、2-OPT、1-PPD在6h时得到最佳衍生化效果。GS在12h达到最佳衍生化时间且后续的12h衍生化效果波动较小,但其他五个化合物的衍生化效果均有不同程度下降,MGO最为显著。因此,选择6h作为最佳衍生化时间。(2) To ensure that the variables are single, the reaction is continuous for 24 hours in units of hours, and five time points (2, 4, 6, 12, and 24 hours) are selected for investigation. It can be concluded from Figure 3 that GO, MGO, 2-OPT and 1-PPD obtained the best derivatization effect at 6h. GS reached the optimal derivatization time at 12h and the derivatization effect of the subsequent 12h fluctuated less, but the derivatization effects of the other five compounds decreased to varying degrees, and MGO was the most significant. Therefore, 6h was chosen as the optimal derivatization time.
(3)鉴于含α-二羰基化合物的实际样品基质较为复杂,其酸碱度可能会随外界因素变化。而对其进行检测分析需要在相对稳定的酸碱环境中,加入缓冲溶液可以极大程度的缓解这一问题。选择PBS缓冲溶液调节pH,在pH 3-10范围内进行优化。从图4可以得出,MGO在pH 7.4时达响应峰值,GO、DA、2-OPT、1-PPD、GS在pH 4-10范围无较大波动,受pH干扰较小。同时pH 7.4条件温和,也是绝大多数生命体培养、生长的酸碱条件,故而选取pH 7.4作为最优衍生化pH。(3) In view of the complexity of the actual sample matrix containing α-dicarbonyl compounds, its pH may vary with external factors. The detection and analysis of it needs to be in a relatively stable acid-base environment, and the addition of buffer solution can greatly alleviate this problem. Choose a PBS buffer to adjust the pH, optimizing in the pH 3-10 range. It can be concluded from Figure 4 that MGO reaches the peak response at pH 7.4, and GO, DA, 2-OPT, 1-PPD, and GS have no major fluctuations in the pH range of 4-10, and are less affected by pH. At the same time, pH 7.4 is mild, and it is also the acid-base condition for the cultivation and growth of most living organisms. Therefore, pH 7.4 is selected as the optimal derivatization pH.
(4)在液质分析中,色谱柱是是样品分离的核心部件。色谱柱需要满足分离效率高、选择性佳、柱效好等要求。当分析目标性质、结构不同时,色谱柱也会出现分离效果不同。为达更好的分离分析目的,本发明选取Diamonsil C18柱(150×2.1mm,粒径3μM)与ΜLtimate XB C18柱(125mm×4.6mm,粒径5μM)对上述六个α-二羰基化合物的分离进行比较。可在图5中得出,Diamonsil C18柱未将上述六个化合物完全分离;而ΜLtimate XB C18柱具有较好的分离效果,响应更高,且耗时较少。综合以上,选取XB C18作为色谱柱。(4) In liquid and mass analysis, the chromatographic column is the core component of sample separation. The chromatographic column needs to meet the requirements of high separation efficiency, good selectivity, and good column efficiency. When the analysis target properties and structures are different, the separation effect of the chromatographic column will also be different. In order to achieve better separation and analysis purposes, the present invention selects Diamonsil C18 column (150 × 2.1 mm,
2、质谱裂解规律结果2. Results of mass spectrometry fragmentation law
以上述最佳条件进行检测,分析α-二羰基化合物衍生化产物的裂解规律:其产物在ESI离子源的正离子模式下,生成[M+H+]的母离子(m/z 234.1),丢失一分子水后,形成碳氮双键,得到m/z 216.0的子离子;又从咪唑环的两处碳氮单键断开,得到m/z 159.1的子离子,该离子响应最高,因此选取m/z 159.1作为定量离子;又在碳氮双键处断裂形成m/z134.1的子离子,具体如图6所示。The detection was carried out under the above optimal conditions, and the cracking rule of the derivatized product of α - dicarbonyl compound was analyzed. After a molecule of water is lost, a carbon-nitrogen double bond is formed, and a product ion of m/z 216.0 is obtained; it is cut off from the two carbon-nitrogen single bonds of the imidazole ring to obtain a product ion of m/z 159.1, which has the highest response, so The m/z 159.1 was selected as the quantitative ion; it was broken at the carbon-nitrogen double bond to form the product ion of m/z 134.1, as shown in Figure 6.
在2-GBI与GO、MGO、DA、2-OPT、1-PPD、GS六个衍生化产物的二级质谱图(如图7所示)中发现,各衍生化产物有着类似的裂解规律。这一规律不仅能够准确判断衍生化反应是否真正发生,还能方便后续解谱与数据分析,并且形成了共同的子离子m/z 159.0与m/z134.0,可根据这一特性利用前体离子扫描模式对非目标性反应性代谢物α-二羰基化合物进行筛查,拓展代谢谱。In the secondary mass spectra of six derivatized products of 2-GBI and GO, MGO, DA, 2-OPT, 1-PPD, and GS (as shown in Figure 7), it was found that the derivatized products had similar cracking rules. This rule can not only accurately judge whether the derivatization reaction really occurs, but also facilitate the subsequent spectrum analysis and data analysis, and form common product ions m/z 159.0 and m/z 134.0, which can be used according to this characteristic. The ion scan mode screens non-target reactive metabolites α-dicarbonyl compounds to expand the metabolic spectrum.
3、衍生化物稳定性考察3. Stability investigation of derivatives
将衍生化物置于24℃、避光环境下,进行稳定性考察。分别在0、2、4、8、16、24h时取样检测,观察其峰面积变化,如图8所示。发现在该储存条件下,保存24h,六种反应性代谢物含量变化幅度较小,均在可接受范围内。Derivatives were placed at 24°C in a dark environment for stability investigation. Samples were taken for detection at 0, 2, 4, 8, 16, and 24 h, respectively, and the peak area changes were observed, as shown in Figure 8. It was found that under this storage condition, the content of six reactive metabolites changed little within 24h, which were all within the acceptable range.
2、液质参数优化2. Liquid quality parameter optimization
对上述六种反应性代谢物建立质谱多反应监测方法,并对其质谱参数进行优化,如母离子、子离子及碰撞电压。优化参数见表4。A mass spectrometry multiple reaction monitoring method was established for the above six reactive metabolites, and the mass spectrometry parameters were optimized, such as precursor ion, product ion and collision voltage. The optimized parameters are shown in Table 4.
表4Table 4
实施例2Example 2
本实施例提供一种中药材中α-二羰基化合物的检测方法,具体如下:The present embodiment provides a method for detecting α-dicarbonyl compounds in Chinese medicinal materials, the details are as follows:
一、试剂与试药1. Reagents and reagents
乌药、厚朴、玉竹、醉鱼草叶、络石藤、补骨脂、柴胡、五味子、吴茱萸、白花蛇草、郁金、淫羊藿、川芎、小蓟、旋覆花、大黄、连翘、生地黄、板蓝根、续断与党参二十一味中草药均购于长沙市本地药店。其他试剂同实施例1。Black medicine, Magnolia officinalis, Polygonatum japonica, Zuiyucao leaves, Coleus vine, Psoraleae, Bupleurum, Schisandra chinensis, Evodia, White snake grass, Turmeric, Epimedium, Chuanxiong, thistle, Inula flower, Rhubarb , Forsythia, Rehmannia glutinosa, Radix Isatidis, Twenty-one Chinese herbal medicines are purchased from local pharmacies in Changsha. Other reagents are the same as in Example 1.
若上述试剂没有做特殊说明,则纯度均大于98%。实验过程中所用水均为ddH2O。If the above reagents do not make special instructions, the purity is greater than 98%. All water used in the experiment was ddH2O.
二、衍生化反应条件与仪器条件2. Derivatization reaction conditions and instrument conditions
1、衍生化反应1. Derivatization reaction
反应在1.5mL离心管中进行,反应液总体积为1mL。按表1依次加入2-胍基苯并咪唑溶液、PBS缓冲溶液、α-二羰基化合物,涡旋2min。在40℃水浴加热条件以及pH为7.4的条件下反应6h后,置于-20℃条件下20min,以终止反应。过0.22μm滤膜,以供LC-MS/MS检测分析。保证至少三个平行样。The reaction was carried out in a 1.5 mL centrifuge tube, and the total volume of the reaction solution was 1 mL. Add 2-guanidinobenzimidazole solution, PBS buffer solution and α-dicarbonyl compound in sequence according to Table 1, and vortex for 2min. After reacting for 6 h under the condition of 40°C water bath heating and pH 7.4, it was placed at -20°C for 20 min to terminate the reaction. Passed through a 0.22 μm filter for LC-MS/MS detection and analysis. Ensure at least three parallel samples.
2、液相色谱-质谱检测分析2. Liquid chromatography-mass spectrometry detection and analysis
(1)液相色谱条件如下:(1) Liquid chromatography conditions are as follows:
分析仪器:三重四极杆液质联用仪(岛津,LC-MS 8050);Analytical instrument: triple quadrupole liquid mass spectrometer (Shimadzu, LC-MS 8050);
色谱柱:ΜLtimate XB-C18(125mm×4.6mm,粒径5μM);Chromatographic column: MLtimate XB-C18 (125mm×4.6mm, particle size 5μM);
流动相A:含0.1%甲酸的水溶液(v/v);Mobile phase A: 0.1% formic acid in water (v/v);
流动相B:甲醇;Mobile phase B: methanol;
流速:1mL/min;Flow rate: 1mL/min;
进样体积:10μL;Injection volume: 10 μL;
洗脱方式:梯度洗脱(洗脱程序如表5所示);Elution mode: gradient elution (the elution program is shown in Table 5);
柱温:22℃。Column temperature: 22°C.
表5table 5
(2)质谱条件如实施例1中3所示,采用正离子模式分析:(2) Mass spectrometry conditions are as shown in 3 in Example 1, and are analyzed in positive ion mode:
三、实验过程3. The experimental process
1、溶液配制1. Solution preparation
准确称取(量取)各标准品(GO,MGO,DA,GS,2-OPT,1-PPD与2-GBI),用甲醇(色谱级)或ddH2O溶解、稀释,得10mM各标准品母液,放置-20℃避光保存。Accurately weigh (measure) each standard (GO, MGO, DA, GS, 2-OPT, 1-PPD and 2-GBI), dissolve and dilute with methanol (chromatographic grade) or ddH2O to obtain 10mM mother solution of each standard , store at -20°C away from light.
2、标准曲线的建立2. Establishment of standard curve
六条标准曲线分别由六个浓度梯度的标准溶液点组成。GO、MGO、DA的浓度在2.25pmol/L-2.25μmol/L范围内,而2-OPT与1-PPD的浓度在90nmol/L-2.25μMol/L,GS的浓度范围在225nmol/L-2.25μmol/L。至少保证三个平行样。The six standard curves consist of six standard solution points of a concentration gradient, respectively. The concentrations of GO, MGO and DA are in the range of 2.25pmol/L-2.25μmol/L, while the concentrations of 2-OPT and 1-PPD are in the range of 90nmol/L-2.25μMol/L, and the concentration of GS is in the range of 225nmol/L-2.25 μmol/L. At least three parallel samples are guaranteed.
衍生化完成后放置在-20℃条件下20min,终止反应。然后将样品过膜处理(0.22μM),进行质谱分析。最终以上述六种反应性代谢物的浓度为横坐标,响应的峰面积为纵坐标,用软件IBM SPSS Statistics 26对数据进行分析处理,得六条标准曲线。After the derivatization was completed, it was placed at -20 °C for 20 min to terminate the reaction. The samples were then processed through a membrane (0.22 [mu]M) and analyzed by mass spectrometry. Finally, taking the concentration of the above six reactive metabolites as the abscissa and the peak area of the response as the ordinate, the software IBM SPSS Statistics 26 was used to analyze and process the data, and six standard curves were obtained.
3、中药材处理3. Treatment of Chinese herbal medicines
准确称取6.00mg中草药于10mL离心管中,加入4mL ddH2O浸润5min,再超声20min。然后加入2mL甲醇,涡旋5min,充分混匀,在15000r/min离心15min,沉淀蛋白,取上清液4mL,再稀释一倍,定容至8mL。-20℃保存,备用。Accurately weigh 6.00 mg of Chinese herbal medicine into a 10 mL centrifuge tube, add 4 mL of ddH2O to infiltrate for 5 min, and then ultrasonicate for 20 min. Then add 2 mL of methanol, vortex for 5 min, mix well, centrifuge at 15,000 r/min for 15 min to precipitate protein, take 4 mL of supernatant, dilute it by one time, and dilute to 8 mL. Store at -20°C for later use.
4、中草药衍生化4. Chinese herbal medicine derivatization
取450μL 2-GBI溶液于1.5mL离心管中,加入100μL PBS缓冲溶液(pH7.4),再加入450μL处理后的中草药溶液,40℃水浴6h,衍生化结束后,置于-20℃条件下20min以终止反应。再经过膜(0.22μm),转移至1.5mL棕色进样瓶,进入质谱仪检测。Take 450 μL of 2-GBI solution into a 1.5 mL centrifuge tube, add 100 μL of PBS buffer solution (pH 7.4), and then add 450 μL of the treated Chinese herbal medicine solution, water bath at 40 °C for 6 hours, and after derivatization, place it at -20 °C 20min to stop the reaction. After passing through the membrane (0.22 μm), it was transferred to a 1.5 mL brown injection bottle and entered into the mass spectrometer for detection.
四、方法学考察4. Methodological investigation
1、线性相关度与灵敏度考察1. Linear correlation and sensitivity investigation
对GO、MGO、DA、2-OPT、1-PPD和GS绘制标准曲线,以浓度倒数(1/c)为权重,使用软件IBM SPSS Statistics 26进行线性回归方程拟合。线性相关度(R)分别为0.934、0.985、0.996、0.991、0.997、0.990,有较好的线性关系,见表6。其定量限与检测限均达到pmol/L级,说明该方法具有较高的灵敏度,可以用于中草药的α-二羰基化合物分析。A standard curve was drawn for GO, MGO, DA, 2-OPT, 1-PPD and GS, with the reciprocal concentration (1/c) as the weight, and the software IBM SPSS Statistics 26 was used to fit a linear regression equation. The linear correlations (R) were 0.934, 0.985, 0.996, 0.991, 0.997, and 0.990, respectively, showing a good linear relationship, as shown in Table 6. The limit of quantification and detection limit reached pmol/L level, indicating that the method has high sensitivity and can be used for the analysis of α-dicarbonyl compounds in Chinese herbal medicines.
表6Table 6
2、准确度考察2. Accuracy inspection
配制六种α-二羰基化合物低、中、高浓度的标准品溶液添加到乌药、白花蛇草中,考察该方法的加标回收率,从而反映该方法的准确度。其实验结果如表7与表8所示。乌药的加标回收率均在91.4-105.8%范围内,白花蛇草的加标回收率均在85.3-113.0%之间。表明该方法具有良好的重现性、稳定性,同时也说明该方法检测结果准确、可靠。Six standard solutions with low, medium and high concentrations of α-dicarbonyl compounds were prepared and added to black medicine and Hedera alba, and the standard addition recovery rate of the method was investigated to reflect the accuracy of the method. The experimental results are shown in Tables 7 and 8. The recovery rates of standard addition of black medicine were in the range of 91.4-105.8%, and the recovery of standard addition of Hedera alba were in the range of 85.3-113.0%. It shows that the method has good reproducibility and stability, and also shows that the detection results of this method are accurate and reliable.
表7乌药的加标回收率Table 7 Spike recovery rate of black medicine
表8百花蛇草的加标回收率Table 8 The recovery rate of standard addition of Hedera japonica
3、精密度考察3. Precision inspection
为评估该方法精密度,对乌药、白花蛇草中六种目标α-二羰基化合物平行检测三次且连续三天进行检测。用平行三次检测的相对标准偏差代表日内精密度,连续三天测样的相对标准偏差反映反应日间精密度,如表9所示。其日内精密度在1.1-10.1%范围,而日间精密度在4.3-14.3%范围。以上数据表明该方法具有较好的精密度,能够应用于乌药与白花蛇草的α-二羰基化合物含量测定。In order to evaluate the precision of the method, six target α-dicarbonyl compounds in black medicine and white snake grass were detected in parallel for three consecutive days for three consecutive days. The relative standard deviation of three parallel tests was used to represent the intra-day precision, and the relative standard deviation of three consecutive three-day testing samples reflected the inter-day precision of the reaction, as shown in Table 9. The intra-day precision was in the range of 1.1-10.1%, while the inter-day precision was in the range of 4.3-14.3%. The above data show that the method has good precision and can be applied to the determination of α-dicarbonyl compounds in black medicine and Hedera chinensis.
表9Table 9
4、实际样品分析4. Analysis of actual samples
完成验证α-二羰基化合物的质谱多反应监测方法后,对乌药及白花蛇草进行定量分析,其检测结果如表10所示。After completing the verification of the mass spectrometry multiple reaction monitoring method for α-dicarbonyl compounds, quantitative analysis of black medicine and Hedera alba was carried out, and the detection results are shown in Table 10.
发现乌药、白花蛇草中α-二羰基化合物含量存在较大的差异,乌药中MGO含量最高,约为0.715μg/g;白花蛇草中DA含量最高,约0.523μg/g。其RSD均在2.51-10.14%内,检测误差在可接受范围内。It was found that the content of α-dicarbonyl compounds in black medicine and white snake grass has a big difference, the MGO content in black medicine is the highest, about 0.715μg/g; the white flower snake grass has the highest DA content, about 0.523μg/g. The RSDs are all within 2.51-10.14%, and the detection errors are within the acceptable range.
表10Table 10
实施例3Example 3
本实施例提供一种细胞中α-二羰基化合物的检测方法,具体如下:The present embodiment provides a method for detecting α-dicarbonyl compounds in cells, the details are as follows:
一、试剂与试药1. Reagents and reagents
过氧化氢(H2O2,30%v/v)、高氯酸(PCA)购于天津鑫源有限公司;甲醇、乙腈、槲皮素均购于伊诺凯科技有限公司;L-丁硫氨酸亚砜亚胺购于上海贤鼎生物科技有限公司;甲酸、酒精(75%,v/v)、葡萄糖(Glu)购于天津市科密欧化学试剂有限公司;MEM培养基、胎牛血清均购于赛默飞世尔科技公司;胰蛋白酶,抗生素均购于上海鼎桑生物科技有限公司;Annexin V-FITC/PI细胞凋亡检测试剂盒,双染细胞凋亡检测试剂盒均购于安诺伦生物科技有限公司;生理盐水购于湖南科伦制药有限公司;MTT试剂盒购于上海生工生物工程股份有限公司;HuMan GLO ELISA 试剂盒购于上海纪宁实业有限公司。其他试剂同2.2.1。Hydrogen peroxide (H2O2, 30% v/v) and perchloric acid (PCA) were purchased from Tianjin Xinyuan Co., Ltd.; methanol, acetonitrile, and quercetin were purchased from Enokay Technology Co., Ltd.; L-butthionine Sulfoxide was purchased from Shanghai Xian Ding Biotechnology Co., Ltd.; formic acid, alcohol (75%, v/v), and glucose (Glu) were purchased from Tianjin Kemeiou Chemical Reagent Co., Ltd.; MEM medium and fetal bovine serum were Purchased from Thermo Fisher Scientific; trypsin and antibiotics were purchased from Shanghai Dingsang Biotechnology Co., Ltd.; Annexin V-FITC/PI apoptosis detection kit and double-stained apoptosis detection kit were purchased in Anhui Noron Biotechnology Co., Ltd.; physiological saline was purchased from Hunan Kelun Pharmaceutical Co., Ltd.; MTT kit was purchased from Shanghai Sangon Bioengineering Co., Ltd.; HuMan GLO ELISA kit was purchased from Shanghai Jining Industrial Co., Ltd. Other reagents are the same as 2.2.1.
若上述试剂没有做特殊说明,则纯度均大于98%。实验过程中所用水均为ddH2O。If the above reagents do not make special instructions, the purity is greater than 98%. All water used in the experiment was ddH 2 O.
二、衍生化反应条件与仪器条件2. Derivatization reaction conditions and instrument conditions
衍生化反应条件与仪器条件均与实施例2中一致。The derivatization reaction conditions and instrument conditions are the same as those in Example 2.
三、实验过程3. The experimental process
1、细胞凋亡模型的建立1. Establishment of apoptosis model
(1)HEK 293细胞复苏(1) HEK 293 cell recovery
首先将ddH2O的温度预调至37℃,再戴上手套、口罩与帽子等防护措施,从液氮罐中取出HEK 293冻存管(内含1mL细胞混合液),立即置于ddH2O(已预调至37℃)中,轻摇,使其在60s内完全溶解。待溶解完成后,用酒精消毒冻存管外壁,并放置在超净台。在超净台中,预先准备一个灭菌离心管,并移取10mL新配制的培养基于该离心管中,再将冻存管中的细胞悬浮液加进去,在常温条件下离心(1000r/min)3min,弃上层培养液。再往HEK 293细胞沉淀中加入1mL培养基,重悬混匀后,转移至T25细胞培养瓶中,并添加培养基至体积为5mL,放置在37℃、5%CO2培养箱培育。两天后更换培养液,待细胞融合约80%时便可进行传代。First, pre-adjust the temperature of ddH2O to 37°C, then put on protective measures such as gloves, masks and hats. Adjusted to 37°C), shake gently to dissolve completely within 60s. After the dissolution is complete, disinfect the outer wall of the cryovial with alcohol and place it on a clean bench. In the ultra-clean bench, prepare a sterilized centrifuge tube in advance, and transfer 10 mL of the newly prepared culture base into the centrifuge tube, then add the cell suspension in the cryopreservation tube, and centrifuge at room temperature (1000r/min) 3min, discard the supernatant medium. Add 1 mL of medium to the HEK 293 cell pellet, resuspend it, transfer it to a T25 cell culture flask, add medium to a volume of 5 mL, and place it in a 37°C, 5% CO2 incubator for incubation. The culture medium was changed after two days, and the cells were passaged when about 80% confluent.
(2)HEK 293细胞培养(2) HEK 293 cell culture
HEK 293细胞用含10%胎牛血清的MEM培养基,在37℃、饱和湿度、含5%CO2的培养箱中培养。HEK 293 cells were cultured in MEM medium containing 10% fetal bovine serum in an incubator at 37°C, saturated humidity, and 5% CO2.
(3)HEK 293细胞铺板(3) HEK 293 cell plating
用0.25%胰酶消化生长状态良好的HEK 293细胞后,进行细胞计数。再将HEK 293细胞种到96孔板中,密度为8000个细胞/孔。待HEK 293细胞稳定后,分别用0、50、100、200、400、800、1600、2000、2500、3000μM H2O2处理,孵育6h后进行MTT检测,通过graphpad prism7.0软件进行分析。Cell counts were performed after well-grown HEK 293 cells were digested with 0.25% trypsin. HEK 293 cells were then seeded into 96-well plates at a density of 8000 cells/well. After the HEK 293 cells were stabilized, they were treated with 0, 50, 100, 200, 400, 800, 1600, 2000, 2500, 3000 μM H2O2, respectively, and incubated for 6 h for MTT detection and analyzed by graphpad prism7.0 software.
(4)HEK 293细胞MTT检测(4) Detection of MTT in HEK 293 cells
HEK 293细胞在孵育处理6h后,每孔加入1/10(v/v)MTT溶液(5mg/mL),然后在37℃、5%CO2培养箱中培养4h。小心吸弃孔内培养上清液,避免吸去紫色结晶。再向每孔中加入100μL DMSO,振荡10min,使紫色结晶物充分溶解。选择490nm作为检测波长,测定各孔光吸收值,记录结果。以浓度为横坐标,相对存活率为纵坐标绘制细胞生长曲线。通过Gradpad软件计算并绘制存活率曲线图,并拍照记录细胞形态。After HEK 293 cells were incubated for 6 h, 1/10 (v/v) MTT solution (5 mg/mL) was added to each well, and then cultured in a 37°C, 5% CO2 incubator for 4 h. Carefully aspirate the culture supernatant from the wells to avoid removing the purple crystals. 100 μL of DMSO was added to each well and shaken for 10 min to fully dissolve the purple crystals. Select 490 nm as the detection wavelength, measure the light absorption value of each well, and record the results. The cell growth curve was plotted with the concentration as the abscissa and the relative viability as the ordinate. The survival rate curve was calculated and drawn by Gradpad software, and the cell morphology was recorded by taking pictures.
2、HEK 293细胞给药实验2. HEK 293 cell administration experiment
(1)HEK 293细胞给药分组(1) HEK 293 cell administration group
根据实验目的分成三个实验组:Divided into three experimental groups according to the purpose of the experiment:
空白对照组:往培养基中添加5mM葡萄糖与50mM H2O2,进行细胞造模;Blank control group: 5mM glucose and 50mM H 2 O 2 were added to the culture medium for cell modeling;
实验组1:往培养基中添加5mM葡萄糖与12μM槲皮素,孵育24h后,再加入50μM H2O2,进行细胞造模;Experimental group 1: 5mM glucose and 12μM quercetin were added to the medium, and after incubation for 24 hours, 50μM H 2 O 2 was added to conduct cell modeling;
实验组2:往培养基中添加5mM葡萄糖与150μM丁硫氨酸亚砜亚胺,孵育24h后,再加入50μM H2O2,进行细胞造模。Experimental group 2: 5 mM glucose and 150 μM butthionine sulfoximine were added to the medium, and after incubation for 24 h, 50 μM H 2 O 2 was added to conduct cell modeling.
以上三组均在加入50mM H2O2后的0、6、16、24、36h时取样,进行细胞凋亡率、GLO酶活性与α-二羰基化合物含量检测。The above three groups were sampled at 0, 6, 16, 24, and 36 h after adding 50 mM H2O2, and the apoptosis rate, GLO enzyme activity and α-dicarbonyl compound content were detected.
HEK 293细胞复苏、培养操作同上。HEK 293 cell recovery and culture operations are the same as above.
(2)细胞凋亡率检测(2) Detection of apoptosis rate
将上述各组细胞离心收集,用4℃生理盐水洗涤细胞2次,再加入500μLPBS缓冲溶液重悬细胞,将其浓度控制在107/mL。然后取100μL细胞悬浮液置于5mL流式管中,加入5μLAnnexin V-FITC,充分混匀后,再加入5μL PropidiuM Iodide混匀,在室温、避光环境下孵育15min。最后用流式细胞仪检测细胞凋亡情况。The cells in the above groups were collected by centrifugation, washed twice with 4°C normal saline, and then added 500 μL of PBS buffer solution to resuspend the cells to control the concentration at 10 7 /mL. Then, 100 μL of cell suspension was placed in a 5 mL flow tube, 5 μL of Annexin V-FITC was added, and after thorough mixing, 5 μL of PropidiuM Iodide was added and mixed, and incubated for 15 min at room temperature in a dark environment. Finally, cell apoptosis was detected by flow cytometry.
(3)GLO酶含量检测(3) Detection of GLO enzyme content
具体操作参考试剂盒说明书,如下:Refer to the kit instructions for specific operations, as follows:
设置标准品孔、待测样本孔与空白孔(空白对照孔不加样品及酶标试剂,其余各步操作相同),标准品孔各加不同浓度的标准品50μL。在酶标包被板上样品孔中先加HEK 293细胞上清稀释液40μL,然后再加HEK 293细胞上清液10μL(样品最终稀释度为5倍)。加样时注意将样品加于酶标板孔底部,且尽量不触及孔壁,轻晃,混匀。每孔加入酶标试剂100μL,空白孔除外。用封板膜将酶标包被板封上后,在37℃下孵育60min。孵育结束后打开封板膜,去除上清液,甩干,每孔加满洗涤液(将浓缩洗涤液用ddH2O稀释20倍),静置30s后去除,该操作重复5次,再甩干。每孔先加入显色剂A 50μL,再加入显色剂B50μL,轻晃,混匀,在37℃、避光环境下显色15min,再加入50μL终止液,终止反应(此时蓝色立转黄色)。以空白孔调零,样品颜色与其GLO酶含量呈正相关,通过酶标仪测量OD450值,绘制GLO标准曲线,再计算得出GLO酶含量。注意测定时间应控制在加入终止液后15min内。Set standard wells, sample wells to be tested and blank wells (blank control wells do not add sample and enzyme labeling reagents, and the rest of the steps are the same), and add 50 μL of standards of different concentrations to each standard well. First add 40 μL of HEK 293 cell supernatant dilution to the sample well of the enzyme-labeled coating plate, and then add 10 μL of HEK 293 cell supernatant (the final dilution of the sample is 5 times). When adding the sample, pay attention to adding the sample to the bottom of the well of the microtiter plate, and try not to touch the wall of the well. Shake gently and mix well. Add 100 μL of enzyme labeling reagent to each well, except for blank wells. After sealing the ELISA-coated plate with a sealing film, incubate at 37°C for 60 min. After the incubation, open the sealing membrane, remove the supernatant, spin dry, fill each well with washing solution (dilute the
3、HEK 293细胞中α-二羰基化合物含量检测3. Detection of α-dicarbonyl compounds in HEK 293 cells
(1)HEK 293细胞前处理(1) Pretreatment of HEK 293 cells
取各样品(含106个HEK 293细胞),加入2mL PBS缓冲溶液,重悬细胞,通过在冰上超声处理15min(10s,1w)裂解细胞,然后加入500μL 1M PCA。再12000r/min离心15min,取上清液备用。Each sample (containing 10 6 HEK 293 cells) was taken, 2 mL of PBS buffer solution was added, cells were resuspended, cells were lysed by sonication on ice for 15 min (10 s, 1 w), and then 500 μL of 1 M PCA was added. Centrifuge at 12000 r/min for 15 min, and take the supernatant for later use.
(2)方法学验证(2) Methodological verification
对HEK 293细胞上清液中的α-二羰基化合物进行衍生,保证至少三个平行样。方法学验证主要考察了日内精密度,日间精密度,加标回收率,LOQ及检测限LOD,对该方法的线性,灵敏度,特异性,重复性,灵敏度进行评价。Derivatization of alpha-dicarbonyl compounds in HEK 293 cell supernatant ensures at least three parallel samples. The method validation mainly examined the intra-day precision, inter-day precision, recovery rate of standard addition, LOQ and detection limit LOD, and evaluated the linearity, sensitivity, specificity, repeatability and sensitivity of the method.
四、实验结果4. Experimental results
1、对GO、MGO、DA、2-OPT、1-PPD和GS绘制标准曲线,以浓度倒数(1/c)为权重,使用软件IBM SPSS Statistics 26进行线性回归方程拟合。线性相关度(R)分别为0.934、0.985、0.996、0.991、0.997、0.990,有较好的线性关系。其定量限与检测限均达到pmol/L级,说明该方法具有较高的灵敏度,可以用于HEK 293细胞中的α-二羰基化合物分析。见表11。1. Draw a standard curve for GO, MGO, DA, 2-OPT, 1-PPD and GS, and use the software IBM SPSS Statistics 26 to fit a linear regression equation with the reciprocal concentration (1/c) as the weight. The linear correlation (R) was 0.934, 0.985, 0.996, 0.991, 0.997, 0.990, respectively, showing a good linear relationship. The limit of quantification and detection limit reached pmol/L level, indicating that the method has high sensitivity and can be used for the analysis of α-dicarbonyl compounds in HEK 293 cells. See Table 11.
表11Table 11
2、通过连续检测三天,每天分别检测三次来考察其精密度。三组细胞样品的日内精密度RSD均在0.5-14.6%之间,日间精密度均在1.4-13.2%范围内。检测结果见表12、表13与表14。2. The precision was examined by three consecutive tests, three times a day. The intra-day precision RSDs of the three groups of cell samples were all in the range of 0.5-14.6%, and the inter-day precisions were all in the range of 1.4-13.2%. The test results are shown in Table 12, Table 13 and Table 14.
表12Table 12
表13Table 13
表14Table 14
3、分别配制10、100与1000nM的标准品溶液添加至不同样品中,测得空白对照组(Glu)得加标回收率均在90.1-114.5%之间,实验组(Que)与实验组(BSO)的加标回收率均在88.2-112.4%与92.5-110.4%范围内。综上,该方法具有较好的准确度、重现性与稳定性。同时也表明该方法具有较高的可信度。3. The standard solutions of 10, 100 and 1000nM were prepared and added to different samples, and the standard addition recovery rates of the blank control group (Glu) were measured to be between 90.1-114.5%. The experimental group (Que) and the experimental group ( The recoveries of spiked BSO) were in the range of 88.2-112.4% and 92.5-110.4%. In conclusion, the method has good accuracy, reproducibility and stability. It also shows that the method has high reliability.
以上所述实施例的各技术特征可以进行任意的组合,为使描述简洁,未对上述实施例中的各个技术特征所有可能的组合都进行描述,然而,只要这些技术特征的组合不存在矛盾,都应当认为是本说明书记载的范围。The technical features of the above-described embodiments can be combined arbitrarily. For the sake of brevity, all possible combinations of the technical features in the above-described embodiments are not described. However, as long as there is no contradiction between the combinations of these technical features, All should be regarded as the scope described in this specification.
以上所述实施例仅表达了本发明的几种实施方式,便于具体和详细地理解本发明的技术方案,但并不能因此而理解为对发明专利保护范围的限制。应当指出的是,对于本领域的普通技术人员来说,在不脱离本发明构思的前提下,还可以做出若干变形和改进,这些都属于本发明的保护范围。应当理解,本领域技术人员在本发明提供的技术方案的基础上,通过合乎逻辑的分析、推理或者有限的试验得到的技术方案,均在本发明所附权利要求的保护范围内。因此,本发明专利的保护范围应以所附权利要求的内容为准,说明书及附图可以用于解释权利要求的内容。The above-mentioned embodiments only represent several embodiments of the present invention, which are convenient for a specific and detailed understanding of the technical solutions of the present invention, but should not be construed as a limitation on the protection scope of the invention patent. It should be pointed out that for those of ordinary skill in the art, without departing from the concept of the present invention, several modifications and improvements can also be made, which all belong to the protection scope of the present invention. It should be understood that the technical solutions obtained by those skilled in the art through logical analysis, reasoning or limited experiments on the basis of the technical solutions provided by the present invention are all within the protection scope of the appended claims of the present invention. Therefore, the protection scope of the patent of the present invention should be based on the content of the appended claims, and the description and drawings can be used to explain the content of the claims.
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210628793.6A CN114858947B (en) | 2022-06-06 | 2022-06-06 | Detection method and application of α-dicarbonyl compounds |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210628793.6A CN114858947B (en) | 2022-06-06 | 2022-06-06 | Detection method and application of α-dicarbonyl compounds |
Publications (2)
Publication Number | Publication Date |
---|---|
CN114858947A true CN114858947A (en) | 2022-08-05 |
CN114858947B CN114858947B (en) | 2023-04-28 |
Family
ID=82624384
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202210628793.6A Active CN114858947B (en) | 2022-06-06 | 2022-06-06 | Detection method and application of α-dicarbonyl compounds |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN114858947B (en) |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20170110795A (en) * | 2016-03-24 | 2017-10-12 | 한국식품연구원 | Analytical method to detect α-dicarbonyl compounds, including glyoxal, methylglyoxal and diacetyl |
CN110672735A (en) * | 2019-09-06 | 2020-01-10 | 天津科技大学 | A method for the detection of α-dicarbonyl compounds in a simulated Maillard reaction system by high performance liquid chromatography-tandem mass spectrometry |
-
2022
- 2022-06-06 CN CN202210628793.6A patent/CN114858947B/en active Active
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20170110795A (en) * | 2016-03-24 | 2017-10-12 | 한국식품연구원 | Analytical method to detect α-dicarbonyl compounds, including glyoxal, methylglyoxal and diacetyl |
CN110672735A (en) * | 2019-09-06 | 2020-01-10 | 天津科技大学 | A method for the detection of α-dicarbonyl compounds in a simulated Maillard reaction system by high performance liquid chromatography-tandem mass spectrometry |
Non-Patent Citations (3)
Title |
---|
CORNELIUS HESS ET AL.: "Clinical and forensic examinations of glycaemic marker methylglyoxal by means of high performance liquid chromatography–tandem mass spectrometry", 《INT J LEGAL MED》 * |
MARCO A. SARAIVA ET AL.: "Mass spectrometric studies of the reaction of a blocked arginine with diketonic α-dicarbonyls", 《AMINO ACIDS》 * |
杨阳 等: "α-二羰基化合物检测方法的研究进展", 《化学与生物工程》 * |
Also Published As
Publication number | Publication date |
---|---|
CN114858947B (en) | 2023-04-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN110849983A (en) | A quantitative analysis method for twelve components of Astragalus Jianzhong pills in rat plasma | |
CN109142572A (en) | A variety of drugs are synchronous in a kind of environment multimedium extracts and determination method | |
CN113533565B (en) | UPLC-MS/MS method for detecting the concentration of 8 kinds of flavonoids in human urine | |
CN111983244A (en) | A kind of detection method and detection kit of four vitamins in dried blood spot | |
CN113391001A (en) | Detection method of glucosinolate compounds | |
WO2024007531A1 (en) | Method for simultaneously measuring content of 24 ingredients in daochi wan | |
Shi et al. | Screening of hepatotoxic compounds in Psoralea corylifolia L., a traditional Chinese herbal and dietary supplement, using high‐resolution mass spectrometry and high‐content imaging | |
CN107831233A (en) | Method for synchronous detection of multiple colorants in traditional Chinese medicine preparations | |
CN104198574A (en) | Double fingerprint spectrum quality control method of Chinese gall | |
CN115290767A (en) | Dissolution rate determination method for 8 representative ingredients in red blood-guiding pill | |
CN114858947B (en) | Detection method and application of α-dicarbonyl compounds | |
Tang et al. | Cell extraction combined with off‐line HPLC for screening active compounds from Coptis chinensis | |
CN107677744A (en) | The detection method of form mercury in a kind of animal tissue cell | |
Wang et al. | Qualitative and quantitative analysis of pyrrolizidine alkaloids for the entire process quality control from Senecio scandens to Senecio scandens‐containing preparations by high performance liquid chromatography‐tandem mass spectrometry | |
CN114216979B (en) | A Quality Evaluation Method of Dried Ginger Based on UPLC-TQ-MS/MS | |
CN110702809A (en) | A method for quality control and evaluation of compound muji granules based on anti-liver fibrosis biological activity | |
Hobert et al. | Acylglycine Analysis by Ultra‐Performance Liquid Chromatography‐Tandem Mass Spectrometry (UPLC‐MS/MS) | |
CN110297059A (en) | A kind of liquid chromatography tandem mass spectrometry quantifies paraquat kit and its preparation in blood plasma | |
CN113671064B (en) | Detection method for quantitatively analyzing blood concentration of amlexanox in plasma | |
Yao et al. | Fast‐switching high‐voltage porous‐tip electrospray ionization mass spectrometry for rapid detection of antirheumatic drugs in adulterated herbal dietary supplements | |
CN108760904A (en) | A kind of method that plasma sample pretreatment technology combination UPLC-MS/MS measures Cefdinir content in human normal plasma | |
CN116298050A (en) | Party and Sitting powder inspection method | |
CN114894915A (en) | A kind of establishment method and application of Jiuxin pill fingerprint | |
CN103869020B (en) | A kind of method differentiating natural musk and muscone | |
CN114113403A (en) | Liquid chromatography-mass spectrometry determination method for Hedan tablets |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |